Table 5.
LAS model & 1- year survival |
LAS variables & 5-year survival |
|
---|---|---|
Area under the curve | 0.580 | 0.566 |
Variables | B coefficient1 | B coefficient |
Recipient age | 0.00351 | 0.00955*** |
Creatinine | 0.0620 | 0.129*** |
NYHA Class | −0.489 | −0.364*** |
FVC | −0.00275 | −0.0000766 |
PCW | 0.0330 | −0.0197 |
Mechanical Ventilation | 0.313 | 0.681*** |
Diagnosis Group2 | ||
B | 0.623 | 0.0991 |
C | 0.00851 | 0.0911 |
D | 0.413 | 0.174 |
Diagnosis detailed | ||
Bronchiectasis | 0.0561 | 0.0297 |
Eisenmenger’ s | 0.394 | 0.583** |
LAM | −0.624 | −0.619** |
Obstructive Bronchiolitis | −0.444 | −0.153 |
Pulmonary Fibrosis other | 0.172 | 0.344*** |
Sarcoid PA mean>30 | −0.122 | 0.157 |
Sarcoid PA mean<30 | −0.0165 | 0.135 |
p < .05,
p < .01,
p < .001
B coefficient derived in the LAS post-transplant model. P-values are N/A.
- Group A = Obstructive lung disease (e.g., emphysema)
- Group B = Pulmonary vascular disease (e.g., primary pulmonary hypertension)
- Group C = Cystic fibrosis or immunodeficiency disorder
- Group D = Restrictive lung disease (e.g. IPF, NSIP, sarcoidosis)